NCT05018611

Brief Summary

The LifeSkills Mobile app will be evaluated in a randomized controlled trial (RCT) among 5,000 young transgender women (YTW), ages 16-29 in the United States (U.S.). Study findings will demonstrate if the intervention will reduce HIV incidence.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,100

participants targeted

Target at P75+ for not_applicable

Timeline
9mo left

Started Jan 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Jan 2022Feb 2027

First Submitted

Initial submission to the registry

August 17, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 24, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

January 22, 2022

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2027

Last Updated

March 31, 2026

Status Verified

March 1, 2026

Enrollment Period

5.1 years

First QC Date

August 17, 2021

Last Update Submit

March 25, 2026

Conditions

Keywords

Transgender women (TGW)PrEPmHealthHIV PreventionSexual Behavior

Outcome Measures

Primary Outcomes (1)

  • HIV incidence

    Participants will be mailed and take an OraQuick In-Home HIV Test. Reactive HIV screening tests will be confirmed via dried blood spot (DBS; detectable antibodies). The main analysis will assess whether there are differences in survival (or cumulative incidence of HIV) among those randomized to LifeSkills Mobile versus those randomized to SOC.

    12-48 months post-baseline (depending on when participants enroll in the study)

Secondary Outcomes (10)

  • Changes in sexual risk behavior at 6 months based on self-report

    6 months post-baseline

  • Changes in sexual risk behavior at 12 months based on self-report

    12 months post-baseline

  • Changes in sexual risk behavior at 18 months based on self-report

    18 months post-baseline

  • Changes in sexual risk behavior at 24 months based on self-report

    24 months post-baseline

  • Changes in sexual risk behavior at 30 months based on self-report

    30 months post-baseline

  • +5 more secondary outcomes

Study Arms (2)

LifeSkills Mobile

EXPERIMENTAL

Access to LifeSkills Mobile app. Participants will complete 4 modules with 20 activities across 6 months. Participants can log in at their convenience but will not be able to access the next module until the previous module is completed.

Behavioral: LifeSkills Mobile

Standard of Care

NO INTERVENTION

HIV home testing every 6 months, information regarding sexual and other behaviors that potentiate one's risk for HIV infection, receipt of a fact sheet about PrEP and PEP and referrals to the local PrEP clinics, and sexually transmitted infection testing via an on-line location findings app.

Interventions

A mobile app designed to facilitate the broad reach and impact of the LifeSkills intervention to reduce sexual risk behavior which drives HIV infection. The LifeSkills intervention addresses the specific structural, developmental, and interpersonal challenges to HIV prevention among YTW ages 16-29, with prior evidence of the efficacy to reduce sexual risk.

LifeSkills Mobile

Eligibility Criteria

Age16 Years - 29 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsSelf-identified as transgender, woman, and/or along the feminine spectrum
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Self-identified as transgender, woman, and/or along the feminine spectrum with a male assigned sex at birth
  • Ages 16-29
  • HIV uninfected at enrollment visit, verified via HIV home test kit
  • Self-reported lifetime history of condomless sex or recent history of sex (anal or vaginal in the past 12 months)
  • Able to speak/understand English
  • Owns a smartphone or home computer or willing to use one in the study
  • Willing and able to provide informed consent/assent

You may not qualify if:

  • Unable to provide informed consent due to severe mental or physical illness, or substance intoxication at time of enrollment
  • Discovery of active suicidal ideation or major mental illness (e.g. untreated psychosis or mania) at the time of the interview (these patients will be referred immediately for treatment, but may join the study when this is resolved)
  • A positive Home HIV test kit result at baseline; these individuals will be immediately linked to HIV clinical care in their local areas.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCLA

Los Angeles, California, 90095, United States

Location

Related Publications (1)

  • Kuhns LM, Garofalo R, Belzer M, McAvoy-Banerjea J, Holzman J, Kwak E, Johnson AK, Biello K, Schnall R, Hidalgo MA, Reisner SL, Mimiaga MJ. Digital limited interaction efficacy trial of LifeSkills Mobile to reduce HIV incidence in young transgender women: study protocol. Trials. 2025 Dec 17;27(1):62. doi: 10.1186/s13063-025-09353-0.

MeSH Terms

Conditions

Sexual Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Marvin Belzer, MD

    Children's Hospital Los Angeles

    PRINCIPAL INVESTIGATOR
  • Matthew J Mimiaga, ScD, MD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR
  • Lisa Kuhns, PhD, MPH

    Ann & Robert H Lurie Children's Hospital of Chicago

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Epidemiology, UCLA Fielding School of Public Health, and Psychiatry & Biobehavioral Sciences, UCLA David Geffen School of Medicine

Study Record Dates

First Submitted

August 17, 2021

First Posted

August 24, 2021

Study Start

January 22, 2022

Primary Completion (Estimated)

February 28, 2027

Study Completion (Estimated)

February 28, 2027

Last Updated

March 31, 2026

Record last verified: 2026-03

Locations